Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

The U.S. Centers for Disease Control and Prevention (CDC) recommends Beyfortus or Enflonsia for babies younger than 8 months ...

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...

Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually ...

Nearly 1,000 flu cases have been reported to the Erie County Department of Health since Oct. 1 but only seven RSV cases have ...

Learn about the FDA's review of the safety of RSV prevention drugs Clesrovimab and Nirsevimab for infants and toddlers. Find ...